Exchange: NYSE·Updated 07:30 PM EDT

OACB Oaktree Acquisition Corp II - Ordinary Shares - Class A

$5.22
$0.05
(0.96%)
Today
Closed $5.24
$0.02
(0.38%)
After Hours
Mkt Cap$2.03B
Vol1.03M

About OACB

Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by Róbert Vilhelm Wessman in 2013 and is headquartered in Luxembourg.
50

Neutral Sentiment

How do you feel about OACB?

Advertisement|Remove ads.